About KKH Torgau
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Acotec Scientific Co., Ltd
1
Daiichi Sankyo, Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
German Breast Group
1
Hoffmann-La Roche
1
PharmaMar
1
University Hospital Tuebingen
1
Clinical Trials at KKH Torgau
During the past decade, KKH Torgau conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients
2015-07-28
2019-09-18
Completed
220
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
2019-06-14
2032-09-30
Active, not recruiting
366
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
2020-10-28
2029-03-30
Recruiting
1,332
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
2020-12-04
2030-12-31
Recruiting
1,600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "KKH Torgau" #1 sponsor was "Acotec Scientific Co., Ltd" with 1 trials, followed by "Daiichi Sankyo, Inc." with 1 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "German Breast Group" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KKH Torgau"
#1 collaborator was "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at KKH Torgau
According to Clinical.Site data, the most researched conditions in "KKH Torgau" are
"Advanced/Metastatic Breast Cancer" (1 trials), "Breast Cancer (Early Breast Cancer)" (1 trials), "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials) and "HER2-Positive Primary Breast Cancer" (1 trials). Many other conditions were trialed in "KKH Torgau" in a lesser frequency.
Clinical Trials Intervention Types at KKH Torgau
Most popular intervention types in "KKH Torgau" are "Drug" (5 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "AcoArt Orchid (0.035"), AcoArt Tulip (0.018") and AcoArt Litos (0.014") percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd." (1 trials), "Blood sampling" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at KKH Torgau
The vast majority of trials in "KKH Torgau" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at KKH Torgau
Currently, there are NaN active trials in "KKH Torgau".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in KKH Torgau,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in KKH Torgau, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".